BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26264475)

  • 1. Preoperative vaginal estrogen and midurethral sling exposure: a retrospective cohort study.
    Cadish LA; West EH; Sisto J; Longoria T; Bebchuk JD; Whitcomb EL
    Int Urogynecol J; 2016 Mar; 27(3):413-7. PubMed ID: 26264475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of vaginal mesh exposure after midurethral sling placement: a case-control study.
    Linder BJ; El-Nashar SA; Carranza Leon DA; Trabuco EC
    Int Urogynecol J; 2016 Sep; 27(9):1321-6. PubMed ID: 26811112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeon volume and reoperation risk after midurethral sling surgery.
    Berger AA; Tan-Kim J; Menefee SA
    Am J Obstet Gynecol; 2019 Nov; 221(5):523.e1-523.e8. PubMed ID: 31526790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence.
    Kokanali MK; Doğanay M; Aksakal O; Cavkaytar S; Topçu HO; Özer İ
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():146-50. PubMed ID: 24793930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of early postoperative voiding dysfunction and other complications following a midurethral sling.
    Ripperda CM; Kowalski JT; Chaudhry ZQ; Mahal AS; Lanzer J; Noor N; Good MM; Hynan LS; Jeppson PC; Rahn DD
    Am J Obstet Gynecol; 2016 Nov; 215(5):656.e1-656.e6. PubMed ID: 27319367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of patient and technical factors associated with midurethral sling mesh exposure and perforation.
    Osborn DJ; Dmochowski RR; Harris CJ; Danford JJ; Kaufman MR; Mock S; Kit LC; McCormick B; Reynolds WS
    Int J Urol; 2014 Nov; 21(11):1167-70. PubMed ID: 25039945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications and risk factors for midurethral sling revision.
    Unger CA; Rizzo AE; Ridgeway B
    Int Urogynecol J; 2016 Jan; 27(1):117-22. PubMed ID: 26134541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the local carcinogenic potential of mesh used in the treatment of female stress urinary incontinence.
    Linder BJ; Trabuco EC; Carranza DA; Gebhart JB; Klingele CJ; Occhino JA
    Int Urogynecol J; 2016 Sep; 27(9):1333-6. PubMed ID: 26864666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translabial US: Preoperative Detection of Midurethral Sling Erosion in Stress Urinary Incontinence.
    Viragh KA; Cohen SA; Shen L; Kurzbard-Roach N; Raz S; Raman SS
    Radiology; 2018 Dec; 289(3):721-727. PubMed ID: 30106346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of excised midurethral sling mesh.
    Hill AJ; Unger CA; Solomon ER; Brainard JA; Barber MD
    Int Urogynecol J; 2015 Apr; 26(4):591-5. PubMed ID: 25377295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing postoperative voiding dysfunction after mid-urethral sling using either a Babcock or Kelly clamp tensioning technique.
    Chang OH; Hacker MR; Rosenblatt PL; Neo D; Von Bargen E; Berrahou I; Le A; Lefevre R; Hota LS
    Int Urogynecol J; 2019 Feb; 30(2):301-305. PubMed ID: 29600405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between polypropylene midurethral slings and malignancy?
    King AB; Zampini A; Vasavada S; Moore C; Rackley RR; Goldman HB
    Urology; 2014 Oct; 84(4):789-92. PubMed ID: 25260443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Preoperative Laboratory Testing in Women Undergoing Suburethral Sling.
    Pandya LK; McLaughlin EM; Hudson CO; Nekkanti S; Smith PE; Hade EM; Hundley AF
    Female Pelvic Med Reconstr Surg; 2019; 25(2):99-104. PubMed ID: 30807408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating anterior vaginal wall prolapse with polypropylene mesh via the transoburator route minimizing the complications with the use of preventing measures. A prospective study with 2-year follow-up.
    Adamakis I; Katafigiotis I; Tyritzis SI; Mygdalis V; Sfoungaristos S; Katafigioti A; Mitropoulos D; Constantinides CA
    Minerva Ginecol; 2015 Jun; 67(3):231-8. PubMed ID: 25668420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vs late midline sling lysis results in greater improvement in lower urinary tract symptoms.
    South MM; Wu JM; Webster GD; Weidner AC; Roelands JJ; Amundsen CL
    Am J Obstet Gynecol; 2009 May; 200(5):564.e1-5. PubMed ID: 19249728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous graft for treatment of midurethral sling exposure without mesh excision.
    Jeppson PC; Sung VW
    Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):437-9. PubMed ID: 23344401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Adverse Events in a Matched Cohort of Women Undergoing Concurrent Midurethral Sling at the Time of Minimally Invasive Benign Gynecologic Surgery.
    Wood N; Casas-Puig V; Ferrando CK
    Urogynecology (Phila); 2022 Dec; 28(12):862-871. PubMed ID: 36409644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between body mass index and pain following transobturator sling.
    Cadish LA; Hacker MR; Modest AM; Rogers KJ; Dessie S; Elkadry EA
    J Obstet Gynaecol; 2017 Aug; 37(6):766-769. PubMed ID: 28366128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is antibiotic prophylaxis necessary for midurethral sling procedures? A series of 174 cases without preoperative antibiotics.
    Harmanli O; Hong EK; Rubin R; Jones KA; Boyer RL; Metz S
    Int Urogynecol J; 2012 May; 23(5):621-3. PubMed ID: 22159591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal erosion after hybrid midurethral sling placement.
    Bong GW; Rovner ES
    Urology; 2006 Dec; 68(6):1343.e13-4. PubMed ID: 17141829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.